HomeNews

News

Opdivo Earlier than and After Surgical procedure Lowers Danger of Recurrence or Demise by 40% in NSCLC

Opdivo Earlier than and After Surgical procedure Lowers Danger of Recurrence or Demise by 40% in NSCLCFor sufferers with resectable (detachable by surgical...

Dealing With the Uncertainty of Most cancers

All of us face uncertainty in our lives — whether or not it considerations the economic system, local weather change, relationships, well being...

Navigating Medical Trials in Gynecologic Cancers

Navigating Medical Trials in Gynecologic CancersMedical trials play a pivotal function in gynecologic cancers, providing sufferers revolutionary therapies whereas contributing to groundbreaking medical...

Proteogenomics Research Identifies Most cancers Drug Targets

September 11, 2024, ...

A New Period in Small Cell Lung Most cancers Therapy

Dr. Debu Tripathy, editor-in-chief of CURE journalThough developments in therapies for small cell lung most cancers (SCLC) are scarce for this aggressive most...

Hot Topics